Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | HPGDS | O60760 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.35 |
| ▸ | QPCT | Q16769 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27340963 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| Hydrochloric Acid SCHEMBL1373085 | 0.98 | TDP1 (0.52) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL12174842 | 0.84 | CYP2C9 (0.50) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL2176873 | 0.82 | CYP2C9 (0.53) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL7842865 | 0.82 | CYP2C9 (0.48) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL25226943 | 0.81 | CYP2C9 (0.39) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL14665172 | 0.81 | CYP2C9 (0.47) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL2629331 | 0.81 | CYP2C9 (0.56) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL12158515 | 0.79 | CYP2C9 (0.46) | CYP2C9TSHRCYP2C19MTORHRH4 | |
| SCHEMBL14664160 | 0.79 | CYP2C9 (0.46) | CYP2C9TSHRCYP2C19MTORHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | claimed |
| WO-2025105959-A1 | SHIKIMATE PATHWAY-DEPENDENT CATABOLIC MICROORGANISM | WAGENINGEN UNIVERSITEIT (NL) | 2025-05-22 | — | — | WO | claimed |
| WO-2025064917-A1 | PROGRAMMABLE BASE EDITING | NORTH CAROLINA STATE UNIVERSITY (US) | 2025-03-27 | — | — | WO | claimed |
| CN-118655322-A | Metabolic-study-based breast cancer detection biomarker and application thereof | 浙江大学 | 2024-09-17 | — | — | CN | claimed |
| WO-2024184403-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR BIOME APS (DK) | 2024-09-12 | — | — | WO | claimed |
| US-20240229012-A9 | SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-07-11 | — | — | US | claimed |
| US-20240132873-A1 | SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY | UNIV NORTH CAROLINA STATE (US) | 2024-04-25 | — | — | US | claimed |
| EP-4291664-A1 | SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY | North Carolina State University (US) | 2023-12-20 | — | — | EP | claimed |
| US-20230399672-A1 | GENOME-MODIFIED BACTERIAL STRAINS FOR LARGE SCALE BIOPROCESSES | UNIVERSITY OF STUTTGART (DE) | 2023-12-14 | — | — | US | claimed |
| CN-108484988-A | A kind of preparation method of the amine-modified modified by nano particles chitosan bacteriostatic film of DOPA | 青岛科技大学 | 2018-09-04 | — | — | CN | claimed |
| CN-108148212-A | A kind of preparation method of chitosan bacteriostatic film and products thereof | 青岛科技大学 | 2018-06-12 | — | — | CN | claimed |
| CN-107761187-A | A kind of method that acid fiber by polylactic is prepared by solution-polymerized SBR | 同济大学 | 2018-03-06 | — | — | CN | claimed |
| CN-105113035-B | Regenerated fiber and preparation method thereof | 北京林业大学 | 2017-12-22 | — | — | CN | claimed |
| CN-106750360-A | A kind of method of the reverse solution system separating lignin of utilization alkali ionic liquid | 华南理工大学 | 2017-05-31 | — | — | CN | claimed |
| CN-105418575-A | Method for extracting natural vitamin E through two-step reextraction method | UNIV EAST CHINA SCIENCE & TECH | 2016-03-23 | — | — | CN | claimed |
| CN-104141151-A | Method for forming metal simple substance through ionic liquid in electrolytic deposition mode | HARBIN INST OF TECHNOLOGY | 2014-11-12 | — | — | CN | claimed |
| CN-103147331-A | Method for extracting biomass cellulose of lignocellulose by using imidazolium ionic liquid | UNIV NANKAI | 2013-06-12 | — | — | CN | claimed |
| CN-100400579-C | Method for preparing functional material of regenerated cellulose | CHINESE ACAD INST CHEMISTRY (CN) | 2008-07-09 | — | — | CN | claimed |
| CN-1796444-A | Method for preparing functional material of regenerated cellulose | CHINESE ACAD INST CHEMISTRY (CN) | 2006-07-05 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | CYP2C9 4531/4885TSHR 2407/4885CYP2C19 4167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.